PMID: 2111204Apr 1, 1990Paper

Valproic acid and panic disorder

Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
F PrimeauL Beauclair

Abstract

Valproic acid (VA), an anticonvulsant which increases GABAergic transmission was given to patients suffering from recurrent panic attacks. Ten consecutive outpatients were included in this study. After a seven day placebo washout period, patients were given a dose of 500 mg/day, which was gradually increased to a maximum of 2250 mg/day. A significant improvement was found in the symptomatology of patients as measured on the Clinical Global Impression Scale for panic severity (p less than 0.001), the Hamilton Psychiatric Rating Scale for Anxiety (p less than 0.001) and the panic factor of the SCL-90 (p less than 0.05). These findings support the hypothesis that VA is useful in the treatment of panic disorders. Further research should be carried out to assess its efficacy and safety.

References

Aug 1, 1985·Acta Neurologica Scandinavica·L Gram, K D Bentsen
Nov 1, 1986·Journal of Clinical Pharmacology·G M PollackD D Shen
Mar 1, 1987·Neurology·F E DreifussK B Menander
Nov 6, 1982·Lancet·C Braestrup, M Nielsen

❮ Previous
Next ❯

Citations

Mar 1, 1994·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·R BowenJ Hawkes
Apr 12, 2003·Bipolar Disorders·Michael J PassmoreMartin Alda
May 16, 2007·Journal of Clinical Psychopharmacology·Marco MulaGiovanni B Cassano
Nov 7, 2007·CNS Spectrums·Jennifer M Rosenberg, Carl Salzman
May 1, 2010·Expert Review of Clinical Pharmacology·Lindsey I SinclairAndrea L Malizia
Jul 1, 1993·Biopharmaceutics & Drug Disposition·Z HusseinG R Granneman
Jun 19, 1992·Pharmaceutisch Weekblad. Scientific Edition·P E Keane
Apr 1, 1996·Journal of Clinical Psychopharmacology·C L Bowden
Aug 16, 2005·Current Psychiatry Reports·Gustavo Kinrys, Lisa E Wygant
Oct 25, 2008·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Borwin BandelowJohann Vega
Apr 1, 2007·Neuropsychiatric Disease and Treatment·Jeffrey R Strawn, Thomas D Geracioti
Jan 1, 1998·International Journal of Psychiatry in Clinical Practice·J M Zajecka, J S Ross
Aug 5, 2000·Journal of Clinical Psychopharmacology·A C PandeT Shiovitz
Apr 19, 2003·International Clinical Psychopharmacology·Gustavo KinrysMarcio Versiani
Aug 10, 1999·Journal of Clinical Psychopharmacology·A C PandeS M Sutherland
Sep 28, 2004·CNS Spectrums·Borwin Bandelow, Eckart Rüther
Oct 20, 2007·European Psychiatry : the Journal of the Association of European Psychiatrists·Nadir A Aliyev, Zafar N Aliyev
Jan 9, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Borwin BandelowUNKNOWN World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive
Oct 23, 2009·CNS Drugs·Marcia Kauer-Sant'AnnaEduard Vieta
Dec 10, 2013·International Journal of Psychiatry in Clinical Practice·Nash N BoutrosMatthew P Galloway
Jan 26, 2000·Journal of Clinical Psychopharmacology·L L DavisF Petty
Oct 1, 2004·Drugs·Michael Van AmeringenMark Bennett
Oct 4, 2008·Journal of Psychopharmacology·J R DavidsonM Versiani
Mar 12, 1998·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·M Baetz, R C Bowen
Apr 6, 2021·Therapeutic Advances in Psychopharmacology·Vasilios G Masdrakis, David S Baldwin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.